Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study

Eligibility Criteria

• * ≥ 18 years of age at the time of study entry.
• * Patients with inoperable NSCLC confirmed by histologic or cytologic documentation and by clinical assessment.
• * Patients have completed at least two cycles of immune checkpoint inhibitors (adjuvant, unresectable, or advanced metastatic disease) as a monotherapy.
• * If adjuvant or unresectable, immunotherapy must be planned for at least one year.
• * If advanced metastatic NSCLC, immunotherapy must be planned for at least two years.
• * Self-reported cancer or treatment related fatigue as noted in the patient's medical record or per treating physician.
• * Life expectancy of greater than 6 months.
• * 18 years of age at the time of study entry.
• * A family member or friend helping a patient with NSCLC would be eligible for this study in any of the following ways as outlined by the National Cancer Institute:
• * Helping with day-to-day activities such as doctor visits or preparing food
• * Giving medicines or helping with physical therapy or other clinical tasks
• * Helping with tasks of daily living such as using the bathroom or bathing
• * Coordinating care and services from a distance by phone or email
• * Giving emotional and spiritual support
• * Patients who are currently receiving or have received chemotherapy and/or radiation within the past 1 year.
• * Diagnosis of dementia.
• * History of clinical depression.
• * Current treatment for sarcopenia and anemia or hemoglobin below 10.
• * Untreated hypothyroidism.
• * Symptomatic heart failure.
• * Oxygen dependent lung disease.
• * Cognitively unable to complete interviews.